Norvasc and Aspirin drug interactions - from FDA reports

Summary

Drug interactions are reported among people who take Norvasc and Aspirin together. This study is created by eHealthMe based on reports of 14,101 people who take Norvasc and Aspirin from FDA, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on amlodipine besylate and aspirin (the active ingredients of Norvasc and Aspirin, respectively), and Norvasc and Aspirin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

What is Norvasc?

Norvasc has active ingredients of amlodipine besylate. It is often used in high blood pressure. (latest outcomes from Norvasc 113,865 users)

What is Aspirin?

Aspirin has active ingredients of aspirin. It is often used in blood clots. (latest outcomes from Aspirin 385,580 users)

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 18, 2019

14,101 people who take Norvasc, Aspirin are studied.


Number of reports submitted per year:

Norvasc and Aspirin drug interactions.

Most common drug interactions over time *:

< 1 month:
  1. Nausea (feeling of having an urge to vomit)
  2. Diarrhoea
  3. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  4. Restlessness (not able to rest)
  5. Cholecystitis (infection of gallbladder)
  6. Electrolyte imbalance
  7. Hyperthyroidism (over activity of the thyroid gland)
  8. Platelet count decreased
  9. Dehydration (dryness resulting from the removal of water)
  10. Anaemia (lack of blood)
1 - 6 months:
  1. Dyspnoea (difficult or laboured respiration)
  2. Chronic kidney disease
  3. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  4. Malignant neoplasm progression (cancer tumour came back)
  5. Back pain
  6. Cheyne-stokes respiration (abnormal pattern of breathing combination of slow and faster)
  7. Liver disorder (liver diseases)
  8. Oral intake reduced
  9. Pneumonia bacterial (pneumonia associated with bacterial infection)
  10. Respiratory failure (inadequate gas exchange by the respiratory system)
6 - 12 months:
  1. Asthenia (weakness)
  2. Headache (pain in head)
  3. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  4. Pleural effusion (water on the lungs)
  5. Oedema peripheral (superficial swelling)
  6. Completed suicide (act of taking one's own life)
  7. Muscular weakness (muscle weakness)
  8. Psychiatric symptom
  9. Abdominal pain
  10. Anaemia (lack of blood)
1 - 2 years:
  1. Renal failure chronic (long lasting kidney dysfunction)
  2. Oedema peripheral (superficial swelling)
  3. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
  4. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
  5. Blood creatinine increased
  6. Blood urea increased
  7. Cardiac failure
  8. Hyperuricaemia (level of uric acid in the blood that is abnormally high)
  9. Urinary tract infection
  10. Hyperkalaemia (damage to or disease of the kidney)
2 - 5 years:
  1. Fatigue (feeling of tiredness)
  2. Hypotension (abnormally low blood pressure)
  3. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  4. Blood uric acid increased
  5. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  6. Rash erythematous (redness of the skin)
  7. Aspartate aminotransferase increased
  8. Cardiac failure
  9. Cerebral infarction (less blood supply to brain resulting tissue damage)
  10. Rash macular (small, flat red spots)
5 - 10 years:
  1. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  2. Anxiety
  3. Death
  4. Pain
  5. Hypotension (abnormally low blood pressure)
  6. Asthenia (weakness)
  7. Coagulopathy (blood's ability to clot is impaired)
  8. Dyspnoea (difficult or laboured respiration)
  9. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  10. Renal failure (kidney dysfunction)
10+ years:
  1. Dehydration (dryness resulting from the removal of water)
  2. Dyspnoea (difficult or laboured respiration)
  3. Neck pain
  4. Blood creatinine increased
  5. Blood urea increased
  6. Diarrhoea
  7. Emotional distress
  8. Gingival bleeding (bleeding gums)
  9. In-stent coronary artery restenosis
  10. Occult blood positive
not specified:
  1. Nausea (feeling of having an urge to vomit)
  2. Fatigue (feeling of tiredness)
  3. Dyspnoea (difficult or laboured respiration)
  4. Pain
  5. Asthenia (weakness)
  6. Diarrhoea
  7. Dizziness
  8. Cardiac failure congestive
  9. Fall
  10. Anaemia (lack of blood)

Most common drug interactions by gender *:

female:
  1. Asthenia (weakness)
  2. Fall
  3. Vomiting
  4. Dizziness
  5. Pain in extremity
  6. Headache (pain in head)
  7. Anxiety
  8. Anaemia (lack of blood)
  9. Oedema peripheral (superficial swelling)
  10. Cardiac failure congestive
male:
  1. Dyspnoea (difficult or laboured respiration)
  2. Fatigue (feeling of tiredness)
  3. Anxiety
  4. Oedema peripheral (superficial swelling)
  5. Chest pain
  6. Renal failure (kidney dysfunction)
  7. Pyrexia (fever)
  8. Drug ineffective
  9. Fall
  10. Hypotension (abnormally low blood pressure)

Most common drug interactions by age *:

0-1:
  1. Chest pain
  2. Diarrhoea
  3. Alopecia (absence of hair from areas of the body)
  4. Anaemia (lack of blood)
  5. Arterial disorder
  6. Bradycardia (abnormally slow heart action)
  7. Brain stem haemorrhage (bleeding into structures of brain stem)
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
  10. Cellulitis (infection under the skin)
2-9:
  1. Nausea (feeling of having an urge to vomit)
  2. Headache (pain in head)
  3. Bacterial infection
  4. Cataract (clouding of the lens inside the eye)
  5. Catheter related infection
  6. Cytomegalovirus infection
  7. Dehydration (dryness resulting from the removal of water)
  8. Diarrhoea
  9. Dyskinesia (abnormality or impairment of voluntary movement)
  10. Enterococcal infection
10-19:
  1. Bacterial pyelonephritis (bacterial kidney infection)
  2. Colitis (inflammation of colon)
  3. Escherichia infection (bacterial infection by escherichia coli)
  4. Klebsiella infection
  5. Serratia infection (bacterial infection)
  6. Abdominal pain
  7. Arteriosclerosis (thickening and hardening of arteries)
  8. Asthenia (weakness)
  9. Bacteria urine identified
  10. Blood bicarbonate increased
20-29:
  1. Pain
  2. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  3. Arthralgia (joint pain)
  4. Skin hypertrophy (skin cells enlarges)
  5. Skin induration (an abnormally hard spot or area on the skin)
  6. Pain in extremity
  7. Joint range of motion decreased (disease of joint movement)
  8. Diarrhoea
  9. Skin discolouration (change of skin colour)
  10. Anxiety
30-39:
  1. Pain
  2. Pain in extremity
  3. Vomiting
  4. Arthralgia (joint pain)
  5. Nausea (feeling of having an urge to vomit)
  6. Oedema (fluid collection in tissue)
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Diarrhoea
  9. Fall
  10. Asthenia (weakness)
40-49:
  1. Pain
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Cardiac failure congestive
  4. Anxiety
  5. Depression
  6. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  7. Chest pain
  8. Nausea (feeling of having an urge to vomit)
  9. Fatigue (feeling of tiredness)
  10. Dyspnoea (difficult or laboured respiration)
50-59:
  1. Dyspnoea (difficult or laboured respiration)
  2. Pain in extremity
  3. Vomiting
  4. Headache (pain in head)
  5. Oedema peripheral (superficial swelling)
  6. Arthralgia (joint pain)
  7. Cardiac failure congestive
  8. Asthenia (weakness)
  9. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  10. Pyrexia (fever)
60+:
  1. Nausea (feeling of having an urge to vomit)
  2. Dyspnoea (difficult or laboured respiration)
  3. Pneumonia
  4. Vomiting
  5. Oedema peripheral (superficial swelling)
  6. Weight decreased
  7. Drug ineffective
  8. Headache (pain in head)
  9. Pain in extremity
  10. Back pain

* Approximation only. Some reports may have incomplete information.

Do you take Norvasc and Aspirin?


You are not alone:




Related publications that referenced our studies


Results from eHealthMe (non-FDA) reports of taking Norvasc and Aspirin together

Drug effectiveness (drug is found to be effective) over time *:
Norvasc:
  • < 1 month: 22% (2 of 9 people)
  • 1 - 6 months: 40% (6 of 15 people)
  • 6 - 12 months: 42% (3 of 7 people)
  • 1 - 2 years: 29% (5 of 17 people)
  • 2 - 5 years: 48% (17 of 35 people)
  • 5 - 10 years: 65% (15 of 23 people)
  • 10+ years: 81% (18 of 22 people)
  • not specified: 0.0% (0 of 0 people)
Aspirin:
  • < 1 month: 33% (1 of 3 people)
  • 1 - 6 months: 25% (1 of 4 people)
  • 6 - 12 months: 12% (1 of 8 people)
  • 1 - 2 years: 45% (5 of 11 people)
  • 2 - 5 years: 53% (22 of 41 people)
  • 5 - 10 years: 52% (13 of 25 people)
  • 10+ years: 72% (16 of 22 people)
  • not specified: 0.0% (0 of 0 people)
Drug effectiveness (drug is found to be effective) by gender *:
Norvasc:
  • female: 45% (27 of 59 people)
  • male: 56% (39 of 69 people)
Aspirin:
  • female: 56% (31 of 55 people)
  • male: 47% (28 of 59 people)
Drug effectiveness (drug is found to be effective) by age *:
Norvasc:
  • 0-1: 100.0% (1 of 1 people)
  • 2-9: 0.0% (0 of 0 people)
  • 10-19: 0.0% (0 of 0 people)
  • 20-29: 0.0% (0 of 0 people)
  • 30-39: 0.0% (0 of 1 people)
  • 40-49: 58.0% (10 of 17 people)
  • 50-59: 29.0% (8 of 27 people)
  • 60+: 57.0% (47 of 82 people)
Aspirin:
  • 0-1: 100.0% (1 of 1 people)
  • 2-9: 0.0% (0 of 0 people)
  • 10-19: 0.0% (0 of 0 people)
  • 20-29: 0.0% (0 of 0 people)
  • 30-39: 100.0% (1 of 1 people)
  • 40-49: 46.0% (7 of 15 people)
  • 50-59: 40.0% (10 of 25 people)
  • 60+: 55.0% (40 of 72 people)
Race of the people *:
  • African American, Non-Hispanic: 4.32 %
  • American Indian/Alaska Native: 0.0 %
  • Asian: 2.59 %
  • Hispanic: 3.46 %
  • Native Hawaiians/Pacific Islanders: 0.0 %
  • Two or more races: 1.44 %
  • White, Non-Hispanic: 88.18 %

* Approximation only.


Related studies

Browse interactions by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Interactions between Norvasc and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Aspirin and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Norvasc and Aspirin
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Norvasc and Aspirin (85,269 reports studied)



FDA reports used in this study


Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.